JTD Reading Tools
How to cite item
Treatment rationale and design of the PROLONG study: safety and efficacy of pembrolizumab as first-line therapy for elderly patients with non-small cell lung cancer
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{JTD}{34848}, author = {Masuda, T., Fujitaka, K., Ishikawa, N., Nakano, K., Yamasaki, M., Kitaguchi, S., Masuda, K., Yamaguchi, K., Sakamoto, S., Horimasu, Y., Kawase, S., Miyamoto, S., Nakashima, T., Iwamoto, H., Shiota, N., Senoo, T., Awaya, Y., Kondo, T., Yoshida, T., Hamada, H., Murakami, I., Hattori, N.}, title = {Treatment rationale and design of the PROLONG study: safety and efficacy of pembrolizumab as first-line therapy for elderly patients with non-small cell lung cancer}, journal = {Journal of Thoracic Disease}, volume = {12}, number = {3}, year = {2020}, url = {https://jtd.amegroups.org/article/view/34848} }